TFOS DEWS II management and therapy report

L Jones, LE Downie, D Korb, JM Benitez-del-Castillo… - The ocular …, 2017 - Elsevier
The members of the Management and Therapy Subcommittee undertook an evidence-
based review of current dry eye therapies and management options. Management options …

Towards more accurate bioimaging of drug nanocarriers: turning aggregation-caused quenching into a useful tool

J Qi, X Hu, X Dong, Y Lu, H Lu, W Zhao… - Advanced Drug Delivery …, 2019 - Elsevier
One of the current challenges in the monitoring of drug nanocarriers lies in the difficulties in
discriminating the carrier-bound signals from the bulk signals of probes. Environment …

Advances in dry eye disease treatment

EC O'Neil, M Henderson… - Current opinion in …, 2019 - journals.lww.com
Clinicians have more options at their disposal in the treatment of dry eye disease than ever
before, including topical medications and devices. SYNOPSIS In this article, we review …

Dry eye syndrome in patients with diabetes mellitus: prevalence, etiology, and clinical characteristics

X Zhang, L Zhao, S Deng, X Sun… - Journal of …, 2016 - Wiley Online Library
There has been substantial progress in our understanding of the ocular surface
system/lacrimal function unit in the past 15 years. Keratoconjunctivitis sicca, more commonly …

Matrix metalloproteinase 9 testing in dry eye disease using a commercially available point-of-care immunoassay

EM Messmer, V von Lindenfels, A Garbe, A Kampik - Ophthalmology, 2016 - Elsevier
Purpose To measure matrix metalloproteinase 9 (MMP-9) in the tear film of patients with dry
eye disease (DED) compared with controls and to correlate clinical findings. Design In a …

Neuropathic corneal pain: approaches for management

G Dieckmann, S Goyal, P Hamrah - Ophthalmology, 2017 - Elsevier
Neuropathic pain is caused by a primary lesion or dysfunction of the nervous system and
can occur in the cornea. However, neuropathic corneal pain (NCP) is currently an ill-defined …

Update in current diagnostics and therapeutics of dry eye disease

P Thulasi, AR Djalilian - Ophthalmology, 2017 - Elsevier
Dry eye disease (DED) represents a heterogeneous group of conditions with tear film
insufficiency and signs and/or symptoms of ocular surface irritation. The clinical …

Autologous serum-based eye drops for treatment of ocular surface disease: a report by the American Academy of Ophthalmology

RM Shtein, JF Shen, AN Kuo, KM Hammersmith, JY Li… - Ophthalmology, 2020 - Elsevier
Purpose To describe the safety and effectiveness of using autologous serum-based eye
drops for the treatment of severe dry eye and persistent corneal epithelial defect. Methods …

Treatment of dry eye disease with autologous platelet-rich plasma: a prospective, interventional, non-randomized study

JL Alio, AE Rodriguez, R Ferreira-Oliveira… - Ophthalmology and …, 2017 - Springer
Introduction The objective of this study was to evaluate the use of autologous platelet-rich
plasma (PRP) eye drops as monotherapy for the treatment of moderate to severe cases of …

Scleral lens use in dry eye syndrome

JC Bavinger, K DeLoss, SI Mian - Current opinion in …, 2015 - journals.lww.com
Scleral lens use in dry eye syndrome : Current Opinion in Ophthalmology Scleral lens use in dry
eye syndrome : Current Opinion in Ophthalmology Log in or Register Subscribe to journalSubscribe …